• Applied Workflows with c-Myc tag Peptide: Precision in Fusio

  2026-04-29

  The c-Myc tag Peptide empowers researchers to achieve high-specificity displacement of c-Myc-tagged fusion proteins, optimizing immunoassay selectivity and reproducibility. This guide delivers experimentally validated workflows, troubleshooting strategies, and a data-driven look at how APExBIO’s c-Myc tag Peptide advances transcription factor and cancer research.

• Gastrin I (human): Mechanisms, Evidence, and GI Research Uti

  2026-04-28

  Gastrin I (human) is a key peptide hormone for studying gastric acid secretion pathways. Its selectivity for CCK2 receptors and robust activation of proton pumps make it indispensable in gastrointestinal physiology and disorder research. APExBIO supplies this reagent at high purity, supporting reproducible workflows.

• Clozapine N-oxide: Precision Tool for Neuronal Activity Modu

  2026-04-28

  Clozapine N-oxide (CNO) enables highly specific, reversible modulation of neuronal circuits via chemogenetics, distinguishing itself as a foundational neuroscience research tool. Its inertness in mammalian systems and selectivity for DREADDs unlock advanced experimental control, as highlighted in recent studies on epilepsy and circuit mapping.

• GGFG Peptide Linkers: Catalyzing Next-Gen Oncology Conjugate

  2026-04-27

  This article dissects the mechanistic foundations and translational strategy behind Gly-Gly-Phe-Gly (GGFG) peptide linkers in the context of drug conjugation and antibody-drug conjugate (ADC) development. By drawing on recent advances in epigenetic targeting for MLL-rearranged acute lymphoblastic leukaemia (ALL), it provides actionable guidance for researchers designing bioconjugates, and positions APExBIO’s GGFG as a critical enabler for precision therapeutics.

• Vitamin D Receptor Drives Ferroptosis-Linked Salivary Dysfun

  2026-04-27

  This study uncovers that upregulation of the vitamin D receptor (VDR) promotes ferroptosis and salivary hyposecretion in female Sod1 knockout (SKO) mice. The findings highlight a sex-specific mechanism linking oxidative stress, VDR signaling, and regulated cell death pathways, with implications for understanding and targeting xerostomia in aging and oxidative stress-associated diseases.

• MG-132 (Z-LLL-al): Proteasome Inhibitor for Apoptosis & Cell

  2026-04-26

  MG-132 (Z-LLL-al) is a potent, cell-permeable peptide aldehyde proteasome inhibitor used to dissect apoptosis and cell cycle arrest in cancer research. It selectively inhibits proteasome activity at nanomolar concentrations and induces oxidative stress and mitochondrial dysfunction, leading to apoptosis. MG-132’s solubility, stability, and workflow parameters enable reproducible results in diverse biological assays.

• Z-IETD-FMK: Advanced Caspase-8 Inhibition in Apoptosis Resea

  2026-04-25

  Explore the scientific depth of Z-IETD-FMK, a specific caspase-8 inhibitor, and its pivotal role in dissecting apoptosis and T cell proliferation. This article delivers unique, evidence-backed insights for advanced assay design and immune cell activation research.

• Scenario-Driven Best Practices with MOG (35-55) Peptide (SKU

  2026-04-24

  This article guides biomedical researchers and lab technicians through real-world assay challenges involving cell viability, proliferation, and neuroinflammation, highlighting how 'MOG (35-55) Peptide' (SKU A8306) ensures experimental rigor. Scenario-based Q&As address protocol design, data interpretation, and vendor selection—backed by peer-reviewed literature and validated product specifications.

• CX-4945 (Silmitasertib): Applied Workflows in CK2 Inhibition

  2026-04-24

  CX-4945 (Silmitasertib) empowers researchers to dissect CK2-regulated pathways in cancer and virology, with robust performance in apoptosis induction and cell cycle arrest assays. Workflow guidance and troubleshooting tips help ensure reproducibility, while recent cross-domain findings open up new avenues for antiviral exploration.

• TPPU in Precision sEH Inhibition: New Insights for Lipidomic

  2026-04-23

  Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, unlocks unprecedented mechanistic clarity and experimental precision in lipid signaling and chronic inflammation research. This article uniquely translates the latest Nrf2 pathway findings into actionable assay strategies for advanced biomedical workflows.

• Optimizing ARCA Capped mRNA Synthesis with HyperScribe Kit

  2026-04-23

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 streamlines ARCA-capped, immune-evasive mRNA production for vaccine and functional RNA research. Integrated workflow, robust nucleotide modifications, and poly(A) tailing empower reproducible results in advanced applications such as in vitro translation and RNA vaccine development.

• Chloroquine Diphosphate: Precision Autophagy Control in AML

  2026-04-22

  Explore the role of Chloroquine Diphosphate as a precise autophagy modulator and TLR7/9 inhibitor in acute myeloid leukemia research. This article delves into advanced mechanistic insights, practical protocol guidance, and the translational impact of recent ferroptosis discoveries.

• E-64d: Advancing Calpain and Cathepsin Inhibition in Cell De

  2026-04-22

  E-64d’s membrane-permeability and irreversible inhibition profile make it the gold standard for dissecting cysteine protease pathways in regulated cell death, neuroprotection, and platelet activation models. This guide demystifies experimental workflows, protocol tips, and troubleshooting strategies, ensuring maximal reproducibility for both novice and expert bench scientists.

• Atrial Natriuretic Peptide: Mechanistic Precision for Transl

  2026-04-21

  This thought-leadership article provides a strategic guide for translational researchers leveraging Atrial Natriuretic Peptide (ANP) in next-generation cardiovascular, renal, and metabolic studies. Integrating mechanistic insights with state-of-the-art experimental validation, it delineates ANP’s role as a vasodilator peptide hormone and positions APExBIO’s high-purity ANP as an essential tool for reproducible, high-impact research.

• CD28-ARS2 Axis Regulates PKM Splicing for T Cell Metabolic F

  2026-04-21

  This study reveals how the CD28-ARS2 axis orchestrates alternative splicing of pyruvate kinase M (PKM) isoforms in CD8+ T cells, promoting metabolic flexibility essential for effective antitumor immunity. The findings highlight a previously unrecognized mechanism linking costimulatory signaling to immunometabolic rewiring, with broad implications for T-cell-based immunotherapy.

407 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page